SIBN
SI-BONE, Inc.−$1.01 (4.76%) At close $20.22 · Today
☾After Hours −$1.17 (5.79%) Nov 2, 7:59 PM ET
About SIBN
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Company
- Headquarters
- Santa Clara, CA
- Employees
- 376 (2026)
- Listed
- Oct 17, 2018
- Exchange
- Nasdaq
- Website
- si-bone.com
- SEC industry
- Surgical & Medical Instruments & Apparatus
- Cylvex sector
- Health Care · Medical Devices
Medical Devices
- Market cap #59 of 163
- P/B #53 of 152
Ranked highest first among stocks Cylvex covers.
- ABTAbbott Laboratories$190.6B+3.73%
- ISRGIntuitive Surgical Inc$154.3B+1.13%
- MDTMedtronic plc$127.0B+2.85%
- SYKStryker Corporation$117.7B+5.12%
- BSXBoston Scientific Corp.$64.23B+5.57%
Financial summary
Related companies
About
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
From company filings and market data · Not investment advice
Price data
52W range and average volume from daily bars (unadjusted, last 252 sessions).
Financials
Consensus estimates
The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.